{"nct_id":"NCT00485732","title":"A Study to Evaluate the Immune Response and Safety of GSK Biologicals' HPV-16/18 L1 VLP AS04 Vaccine/Cervarix TM Vaccine in Healthy Females Aged 15-25 Years","status":"COMPLETED","status_verified_date":"2016-11","start_date":"2007-06-11","start_date_type":null,"primary_completion_date":"2008-03-30","primary_completion_date_type":"ACTUAL","completion_date":"2008-03-30","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["GSK"]}